Advisornet Financial’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Advisornet Financial’s Portfolio SIOX Stock Details SIOX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-12	Closed	–	–	2042
2021 Q2	$0	Hold	12	–	–	﹤0.01%	1892
2021 Q1	$0	Hold	12	–	–	﹤0.01%	1861
2020 Q4	$0	Hold	12	–	–	﹤0.01%	1886
2020 Q3	$0	Hold	12	–	–	﹤0.01%	1930
2020 Q2	$0	Hold	12	–	–	﹤0.01%	1975
2020 Q1	$0	Hold	12	–	–	﹤0.01%	1985
2019 Q4	$0	Hold	12	–	–	﹤0.01%	2034
2019 Q3	$0	Hold	12	–	–	﹤0.01%	1998
2019 Q2	$0	Buy	+12	New	+$91	﹤0.01%	1824
2019 Q1	–	Sell	-13	Closed	–	–	1684
2018 Q4	$0	Hold	13	–	–	﹤0.01%	1608
2018 Q3	$0	Hold	13	–	–	﹤0.01%	1658
2018 Q2	$0	Hold	13	–	–	﹤0.01%	1674
2018 Q1	$0	Hold	13	–	–	﹤0.01%	1478
2017 Q4	$1K	Buy	+13	New	+$583	﹤0.01%	1242

Other funds holding SIOX

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Advisornet Financial's SIOX Position: Q3 2021 in Review

Advisornet Financial sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q3 2021, closing a stake of 12 shares.

Advisornet Financial first reported a position in SIOX in Q4 2017 and held it in 14 quarters. The position peaked at $1K in Q4 2017. 56 funds tracked by Wall St. Rank hold SIOX as of Q3 2021.

Advisornet Financial reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
Advisornet Financial sold 12 Sio Gene Therapies Inc. Common Stock shares in Q3 2021.
Advisornet Financial first reported a position in Sio Gene Therapies Inc. Common Stock in Q4 2017 and held it in 14 quarters.
Advisornet Financial's Sio Gene Therapies Inc. Common Stock position peaked at $1K in Q4 2017.
56 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q3 2021.

Based on Advisornet Financial's 13F filing for Q3 2021, filed 15 Oct 2021.